Filing Details

Accession Number:
0000899243-22-002477
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-19 18:26:11
Reporting Period:
2022-01-14
Accepted Time:
2022-01-19 18:26:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seagen Inc. SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202335 W David Gryska 21823 30Th Drive Se
Bothell WA 98021
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-14 4,500 $20.06 50,750 No 4 M Direct
Common Stock Disposition 2022-01-14 4,500 $135.24 46,250 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2022-01-14 4,500 $0.00 4,500 $20.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,000 2022-05-17 No 4 M Direct
Footnotes
  1. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. Options were fully vested on 5/17/13.